AIM ImmunoTech Inc.
AIM· NYSE
AIM ImmunoTech Inc.
- Last sale
- Oct 1, 2026 · +5.01%
- Market cap
- $5.67M
- 30.44M shares
- Filings
- 1,030
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $88,000 | reported | |
| FY 2024 | 2024-12-31 | $170,000 | reported | |
| FY 2023 | 2023-12-31 | $202,000 | reported | |
| FY 2022 | 2022-12-31 | $141,000 | reported | |
| FY 2021 | 2021-12-31 | $135,000 | reported | |
| FY 2020 | 2020-12-31 | $163,000 | reported | |
| FY 2019 | 2019-12-31 | $140,000 | reported | |
| FY 2018 | 2018-12-31 | $367,000 | reported | |
| FY 2017 | 2017-12-31 | $437,000 | reported | |
| FY 2016 | 2016-12-31 | $92,000 | reported | |
| FY 2015 | 2015-12-31 | $133,000 | reported | |
| FY 2014 | 2014-12-31 | $197,000 | reported |
AIM ImmunoTech Inc. · CIK 946644 · Engraved from SEC EDGAR
